Immunome

Immunome is a biopharmaceutical company that utilizes its proprietary human memory B cell platform to discover and develop first-in-class antibody therapies to transform current disease treatment approaches. Immunome is currently collaborating with the U.S. Department of Defense (DoD) to develop a treatment for the SARS-CoV-2 virus and the COVID-19 pandemic.Immunome was initially incorporated in Pennsylvania in March 2006 and reincorporated in Delaware in December 2015.